Editorial policy

Acta Marisiensis Seria Medica is a multidisciplinary journal devoted to publishing original scientific papers, review articles, case reports and reviews from medical sciences, as well as editorials, letters to the editor, commentaries and replies of the authors. The journal is peer-reviewed and is published 4 times a year in both paper and electronic versions. The language of Acta Marisiensis Seria Medica is English. All submitted manuscripts must be accompanied by a cover letter signed by all authors, stating that the article is original, is not under consideration or has not been previously published elsewhere. Authors document that their research was approved by the appropriate institutional review committee for the protection of human or animal subjects, and that all human subjects or their representatives gave informed consent. All submissions are subject to peer review, and to language- and copy-editing after acceptance. At least two independent scientists act as referees of one manuscript. Reviewers evaluate manuscripts critically but constructively to prepare detailed comments about the research and the manuscript to help authors improve their work. The identities of the reviewers will not be released to authors. Reviewers are asked to make one of four recommendations: accept, accept after minor revision, accept after major revision, reject. The decision to ask for revisions is made in light of the reviewers' comments and recommendations, and after evaluation by the editor. The editor may reject manuscripts without outside review, for example if the subject matter is outside the scope of the journal, a manuscript on the same topic is just about to be published, the quality of the manuscript is poor, or criteria for the submission of manuscripts are not met.

 

Copyright

Acta Marisiensis Seria Medica provides immediate open access to its content under the Creative Commons BY 4.0 license. Authors who publish with this journal retain all copyrights and agree to the terms of CC BY 4.0 license.

Plagiarism Policy

The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and AI generation tools, and provide a high standard and quality peer-review process.

Informed consent

All research studies involving human subjects must have received approval of the appropriate institutional ethics committee and informed consent must be obtained from all the patients participating in the studies, prior to manuscript submission.

In cases where the institutional ethics review committee ruled that approval from them was not required or that the need for informed consent was unnecessary, a statement from the committee to this end should be forwarded to the Editor with the manuscript.

Human and animal rights

Studies involving experimental research on animals or humans must conform to the guiding principles of the Declaration of Helsinki. In order to respect a patient`s right to privacy, identifying information such as patients` names, images, initials of hospital numbers should not be included in any published material (tables, figures, text), unless the information is essential for scientific content. In these cases written permission must be obtained from the patient, and should be submitted to the editorial office at the time of manuscript submission. In the case of animal experiments, both national and the institutional guidelines pertaining to the experimental use of laboratory animals should be rigidly followed.

Conflict of interest

The manuscript should contain a statement fully disclosing any conflict of interest related to the manuscript. If there are no conflicts of interest, this should be stated as “none declared”. Material and financial support should also be acknowledged.

Scientific misconduct

Scientific misconduct includes data fabrication, falsification, plagiarism, redundant publication, ghost authorship or other fraudulent research practices. In order to prevent plagiarism issues, all manuscripts sent to the journal will be screened using anti-plagiarism soft-ware. Where there is a suspicion of scientific misconduct, the Editor will act in conformity with the principles stated in the COPE guidelines and if the fraudulent practice is confirmed the manuscript will be rejected outright and without the Editor entering into any further correspondence.

Clinical trials

In case of manuscripts presenting clinical trials, the clinical trial should be registered in a public trials registry at or before the time of first patient enrollment, as a condition for consideration for publication. Trials should be preferably registered in ClinicalTrials.gov, but any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) is acceptable, in accordance with the guidelines of the International Committee of Medical Journal Editors.